Skip to main content

Our Cancer Biology Division has as its focus the molecular underpinnings of cancer etiology and radiation response, and application of this knowledge to new cancer drug discovery.

The Division consists of four faculty members whose research efforts encompass both mechanistic studies of the basis of cancer development and maintenance and translational research into molecular target validation and new drug and biomarker discovery. Similarly, our research on cellular responses to radiation bridges both types of research. Our internationally recognized investigators use state-of-the-art model systems and animal-, cell- and in vitro–based biological, biochemical, and molecular biology techniques to study oncogenes and tumor suppressor genes.

We are a highly collaborative group and maintain close associations with colleagues within the department, the UNC Lineberger Comprehensive Cancer Center, and with top investigators both nationally and internationally from academia and the pharmaceutical industry.